Showing results (1-10 of 129) with videos related to
Sort By:
Pageof 13
Methods in Molecular Biology (Clifton, N.J.)|August 29, 2025
IP6 Kinase Inhibitor Screening AssaysHuijun Wei, James C BarrowBioorganic & Medicinal Chemistry Letters|August 26, 2019
Synthesis and characterization of novel isoform-selective IP6K1 inhibitorsMichael M Wormald, Glen Ernst, Huijun Wei, et al.Scientific Reports|February 17, 2016
Schizophrenia-Associated hERG channel Kv11.1-3.1 Exhibits a Unique Trafficking Deficit that is Rescued Through Proteasome Inhibition for High Throughput ScreeningNicholas E Calcaterra, Daniel J Hoeppner, Huijun Wei, et al.CNS & Neurological Disorders Drug Targets|April 10, 2012
Inhibitors of Catechol-O-MethyltransferaseJames C BarrowACS Medicinal Chemistry Letters|May 18, 2019
A Medicinal Chemist's Perspective on Transitioning from Industry to Academic Drug DiscoveryJames C BarrowACS Chemical Neuroscience|September 7, 2019
Development of a PC12 Cell Based Assay for Screening Catechol-O-methyltransferase InhibitorsGongliang Zhang, Ingrid P Buchler, Michael DePasquale, et al.Biomolecules|September 28, 2023
The Role of Inositol Hexakisphosphate Kinase in the Central Nervous SystemTyler Heitmann, James C BarrowACS Chemical Neuroscience|February 21, 2014
Classics in chemical neuroscience: diazepam (valium)Nicholas E Calcaterra, James C BarrowACS Medicinal Chemistry Letters|December 20, 2023
Fragment-Based Screening Identifies New Quinazolinone-Based Inositol Hexakisphosphate Kinase (IP6K) InhibitorsTyler Heitmann, Gangling Liao, Pablo de León, et al.Journal of Medicinal Chemistry|August 3, 2024
Identification and Characterization of a Blood-Brain Barrier Penetrant Inositol Hexakisphosphate Kinase (IP6K) InhibitorTyler Heitmann, Gangling Liao, Glen Ernst, et al.Pageof 13